Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
Purpose To evaluate the immunogenicity of COVID-19 vaccines in patients with diabetes
mellitus (DM) through a systematic approach. Method A comprehensive search was …
mellitus (DM) through a systematic approach. Method A comprehensive search was …
Multiple COVID-19 waves and vaccination effectiveness in the United States
(1) Background: The coronavirus 2019 (COVID-19) pandemic has caused multiple waves of
cases and deaths in the United States (US). The wild strain, the Alpha variant (B. 1.1. 7) and …
cases and deaths in the United States (US). The wild strain, the Alpha variant (B. 1.1. 7) and …
[HTML][HTML] Clinical characteristics, transmissibility, pathogenicity, susceptible populations, and re-infectivity of prominent COVID-19 variants
Z Yang, S Zhang, YP Tang, S Zhang, DQ Xu… - Aging and …, 2022 - ncbi.nlm.nih.gov
In addition to the rapid, global spread of SARS-CoV-2, new and comparatively more
contagious variants are of considerable concern. These emerging mutations have become a …
contagious variants are of considerable concern. These emerging mutations have become a …
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
Background: Information on SARS-CoV-2 in representative community surveillance is
limited, particularly cycle threshold (Ct) values (a proxy for viral load). Methods: We included …
limited, particularly cycle threshold (Ct) values (a proxy for viral load). Methods: We included …
Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines
Observational studies of the effectiveness of vaccines to prevent COVID-19 are needed to
inform real-world use. Such studies are now underway amid the ongoing rollout of SARS …
inform real-world use. Such studies are now underway amid the ongoing rollout of SARS …
SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: a prospective cohort study in keyworkers
D Wyllie, R Mulchandani, HE Jones, S Taylor-Phillips… - MedRxiv, 2020 - medrxiv.org
Background Immune correlates of protection from COVID-19 are important, but incompletely
understood. Methods We conducted a prospective cohort study in 2,826 participants working …
understood. Methods We conducted a prospective cohort study in 2,826 participants working …
Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals.
Background Recent reports have suggested that among individuals previously infected with
SARS-CoV-2, a single mRNA vaccine dose is sufficient to elicit high levels of immunity …
SARS-CoV-2, a single mRNA vaccine dose is sufficient to elicit high levels of immunity …
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis
MRO Chisale, S Ramazanu, SE Mwale… - Reviews in Medical …, 2022 - Wiley Online Library
We estimated the seroprevalence of anti‐severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) antibodies in residents of African countries and explored its associated …
(SARS‐CoV‐2) antibodies in residents of African countries and explored its associated …
Beschlussentwurf der STIKO zur 4. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung
S Vygen-Bonnet, J Koch, C Bogdan, T Harder… - 2021 - edoc.rki.de
Die STIKO empfiehlt die Impfung gegen COVID-19 mit einem der beiden zugelassenen
mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder …
mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder …
SARS-CoV-2 reinfection rate and estimated effectiveness of the inactivated whole virion vaccine BBV152 against reinfection among health care workers in New Delhi …
Importance A surge of COVID-19 occurred from March to June 2021, in New Delhi, India,
linked to the B. 1.617. 2 (Delta) variant of SARS-CoV-2. COVID-19 vaccines were rolled out …
linked to the B. 1.617. 2 (Delta) variant of SARS-CoV-2. COVID-19 vaccines were rolled out …